Van Kesteren
Andre Van Kesteren, Oakville CA
Patent application number | Description | Published |
---|---|---|
20120230683 | System and Method for Remotely Monitoring Communication Equipment and Signals - Several systems and method for remotely monitoring a communication system are disclosed. An RF signal received at a remote facility is analyzed at the remote facility and an ancillary data signal including information relation to at least one characteristic of the RF signal is generated. The ancillary data signal is modulated and combined with the RF signal. The combined RF signal is transmitted to a local facility in an optical form, where the ancillary data signal is recovered. An ancillary data signal block provides control signal in response to the local ancillary data signal. The control signals may be local control signals for controlling local devices or remote control signals for controlling devices at the remote facility. The ancillary data may include a power level of the RF signal and a version of the RF signal may be generated at the local facility with a power level approximately equal to the power level of the original RF signal. | 09-13-2012 |
Hans Van Kesteren, Eindhoven NL
Patent application number | Description | Published |
---|---|---|
20100020326 | BACKGROUND ACOUSTIC SIGNAL SUPPRESSION IN PHOTOACOUSTIC DETECTOR - The present invention relates to a photo-acoustic device ( | 01-28-2010 |
Hans W. Van Kesteren, Eindhoven NL
Patent application number | Description | Published |
---|---|---|
20100007889 | SAMPLE CONCENTRATION DETECTOR WITH TEMPERATURE COMPENSATION - A sample sensor ( | 01-14-2010 |
Maria Anna Van Kesteren, Leiden NL
Patent application number | Description | Published |
---|---|---|
20130337478 | Antigen-Binding Protein Directed Against Epitope in the CH1 Domain of Human IgG Antibodies - The present disclosure relates to a method for the purification of a human IgG-CH1 domain comprising molecule using an antigen-binding protein that is capable of binding to an epitope that is comprised in the CH1 domain of each of human IgG1, human IgG2, human IgG3 and human IgG4. The disclosure further relates to the antigen-binding proteins that can be used in the method of the disclosure. The frame-work regions of the antigen-binding proteins of the invention preferably correspond to those of antibodies that naturally are devoid of light chains as may e.g. be found in camelids. The disclosure further relates to nucleic acids that encode such antigen-binding proteins, to immunoadsorbent materials that comprise such proteins, and to the uses of such immunoadsorbent materials for the purification of IgG-CH1 domain containing molecules from a variety of species. | 12-19-2013 |
Petronella Cornelia Elisabeth Van Kesteren, Harderwijk NL
Patent application number | Description | Published |
---|---|---|
20120122727 | IN VITRO METHOD FOR PREDICTING WHETHER A COMPOUND IS GENOTOXIC IN VIVO - The invention is in the field of genomics and it provides an in vitro method for predicting whether a compound is genotoxic in vivo. It provides a method that employs the analysis of expression profiles of primary mouse hepatocytes as an in vitro system to discriminate false GTX compounds from true GTX carcinogens. It was found that differential expression of a number of genes could reliably predict whether a compound was a true genotoxic compound. | 05-17-2012 |
Renatus Rolandus Adrianus Paulus Van Kesteren, New York, NY US
Patent application number | Description | Published |
---|---|---|
20100169236 | Multi-Level Leverage Account Structure - An investment structure for multiple classes of investors that combines the advantages of both the master feeder structure and the reverse master feeder structure with segregated accounts. In particular, an investment structure is formed in which investors invest in a common fund. The common fund, in turn, opens a common prime brokerage account, having at least three sub-accounts, for example: an unlevered account; one or more levered accounts and a general trading account. The prime broker provides class loans to the levered account and margin loans to the general trading account. To the extent class loans are provided to the levered account, levered investors will participate in the returns on the general account as if the levered investors invested capital plus the amount of any class loans to that levered account. The unlevered investors will participate in the returns on the general trading account on the basis of their capital contributions alone. The prime broker will have no recourse against any assets of any account other than the levered account as a result of a default or margin call of the levered account. In an alternative embodiment of the invention, the investment structure is structured as a fund of funds, in which multiple classes of investors invest, which, in turn, invests in multiple investment funds, or a fund that employs alternative investment strategies that overlay the basic trading strategies. In this embodiment, a credit facility is established with the equivalent of three sub-accounts as discussed above. | 07-01-2010 |
Ronald Ernst Van Kesteren, Almere NL
Patent application number | Description | Published |
---|---|---|
20100048678 | Nucleic acids and polypeptides that are useful in controlling neuronal regeneration - The present invention relates to methods for promoting regeneration response of peripheral and central nervous systems in mammals in need of such biological effects. The methods comprise altering the activity or steady state level of specific polypeptides that control regeneration of injured or degenerated neuronal cells. Preferably the activity or steady state level of specific polypeptides is altered by introducing nucleic acids to increase or decrease expressing of the polypeptides. These are useful in or suffering from neurodegenerative disorders. | 02-25-2010 |
20100273865 | Polypeptides involved in neuronal regeneration-associated gene expression - The present invention relates to methods for promoting regeneration response of peripheral and central nervous systems in mammals in need of such biological effects. The methods comprise altering the activity or steady state level of specific transcription factors that control regeneration of injured or degenerated neuronal cells. Preferably the activity or steady state level of specific transcription factors is altered by introducing nucleic acids to increase or decrease expressing of these transcription factors. These are useful in or suffering from neurodegenerative disorders. | 10-28-2010 |
Tom A. Van Kesteren, Almere NE
Patent application number | Description | Published |
---|---|---|
20140148924 | SCHEDULER FOR PROCESSING SYSTEM - A semiconductor processing system that includes a controller is disclosed. The controller may be configured to schedule the operation of the system. The controller may be programmed to determine a current state of the system. The current state may be defined at least by a location of one or more substrates and a processing status of the one or more substrates. The controller may be further programmed to generate a search tree having one or more branches. Each branch may identify one or more subsequent actions or branch pathways capable of being performed by the system in the current state. Further, the controller may be programmed to score each branch pathway of the generated search tree. The controller may be programmed to select a branch pathway and provide instructions to perform the actions in that branch pathway based at least in part on the score of the branch pathway. | 05-29-2014 |